How should chronic hypertension be managed in the operating room?

Intraoperative Hypertension Management

Patients with intraoperative hypertension should be managed with intravenous medications until oral medications can be resumed, with specific agents including clevidipine, nicardipine, esmolol, or nitroglycerin depending on the clinical context. 1

Immediate Assessment and Treatment Approach

Before initiating pharmacologic therapy, assess and address contributing factors:

• Volume status - check for fluid overload or depletion
• Pain control - ensure adequate analgesia
• Oxygenation - verify adequate ventilation and oxygen delivery
• Bladder distention - consider urinary catheter placement if needed 2, 1

Intravenous Medication Selection

The choice of IV antihypertensive depends on the surgical context and patient comorbidities:

First-Line Agents:

• Clevidipine - particularly effective for perioperative hypertension, with evidence showing superiority over other agents without increased adverse events 2
• Nicardipine - reliable calcium channel blocker for most surgical scenarios
• Esmolol - preferred when tachycardia accompanies hypertension or in patients with coronary disease
• Nitroglycerin - especially useful in cardiac surgery or acute coronary syndromes 3, 4

Clinical Context Considerations:

During anesthesia induction and airway manipulation (most common timing):

• Use short-acting agents like esmolol or clevidipine for rapid titration 3, 4

In patients with coronary disease:

• Avoid excessive tachycardia; beta-blockers (esmolol) or nitroglycerin preferred 4

Avoid beta-blockers when:

• Moderate-to-severe heart failure with pulmonary edema present
• Bradycardia (<60 bpm)
• Hypotension (SBP <100 mmHg)
• Second- or third-degree heart block
• Reactive airways disease 4

Blood Pressure Targets

While treating intraoperative hypertension, maintain careful balance to avoid hypotension, which causes more harm than moderate hypertension 5:

• Avoid hypotension defined as MAP <60-65 mmHg or SBP <90 mmHg for >15 minutes 6, 5
• Systolic pressures between 120-200 mmHg show no association with acute kidney injury or myocardial injury in general surgery 5
• Treat hypertension incrementally with primary goal of avoiding hypotension 5

Critical Pitfalls to Avoid

1. Do not abruptly discontinue beta-blockers or clonidine - this causes rebound hypertension and is potentially harmful 1, 2

2. Overly aggressive treatment - moderate hypertension (SBP 120-200 mmHg) appears relatively benign compared to hypotension, which definitively causes organ injury 5

3. Delayed recognition - continuous arterial pressure monitoring (invasive or non-invasive) detects hypotension 2-10 times more effectively than intermittent cuff measurements and should be strongly considered for high-risk patients 5

Transition to Oral Therapy

Resume oral antihypertensive medications as soon as clinically reasonable postoperatively:

• Delayed resumption of ACE inhibitors/ARBs is associated with increased 30-day mortality 6
• Continue chronic beta-blockers throughout the perioperative period 1
• Caution against intensifying antihypertensive therapy at discharge due to increased readmission risk 6

Evidence Quality Note

The recommendations for IV medication use are based on expert consensus (Class I, Level C-EO) rather than high-quality RCTs, as no such trials exist for intraoperative hypertension management 2, 1. The clevidipine data represents the strongest available evidence from prospective studies in cardiac surgery 2.